National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A10BK01	ZYGLOR 10	G	Dapagliflozin - 10mg	10mg	Tablet, film coated	2,039,953 L.L
L02BG03	ZORTEX	G	Anastrozole - 1mg	1mg	Tablet, film coated	1,944,092 L.L
C09CA04	ZIOREL	G	Irbesartan - 150mg	150mg	Tablet, film coated	575,933 L.L
C09CA04	ZIOREL	G	Irbesartan - 300mg	300mg	Tablet, film coated	575,933 L.L
J01DC02	ZILISTEN	G	Cefuroxime (sodium) - 750mg	750mg	Injectable dry powder	155,886 L.L
J01DC02	ZINOXIMOR	G	Cefuroxime (axetil) - 500mg	500mg	Tablet, film coated	698,798 L.L
N03AX14	ZITERA	G	Levetiracetam - 500mg	500mg	Tablet, film coated	2,203,902 L.L
R06AE09	ZOLICIN	G	Levocetirizine dihydrochloride - 5mg	5mg	Tablet, film coated	228,453 L.L
R06AE09	ZOLICIN	G	Levocetirizine dihydrochloride - 0.5mg/ml	0.5mg/ml	Solution	663,858 L.L
C10AX09	ZEMIL	G	Ezetimibe - 10mg	10mg	Tablet	944,529 L.L
N03AX14	ZITERA	G	Levetiracetam - 1,000mg	1,000mg	Tablet, film coated	3,225,222 L.L
C07AB07	ZIOPROL	G	Bisoprolol - 5mg	5mg	Tablet, film coated	409,552 L.L
J01XA01	ZERMACIN	G	Vancomycin (HCl) - 0.5g	0.5g	Injectable sterile lyophilised powder for solution	840,861 L.L
C09DA04	ZIOREL PLUS	G	Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	559,294 L.L
J01XA01	ZERMACIN	G	Vancomycin (HCl) - 0.5g	0.5g	Injectable sterile lyophilised powder for solution	5,875,791 L.L
J01XA01	ZERMACIN	G	Vancomycin (HCl) - 1g	1g	Injectable lyophilised powder for solution	1,066,115 L.L
J01XA01	ZERMACIN	G	Vancomycin (HCl) - 1g	1g	Injectable lyophilised powder for solution	6,911,190 L.L
C09DA04	ZIOREL PLUS	G	Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	559,294 L.L
N06AB10	ZELAX 10	G	Escitalopram (oxalate) - 10mg	10mg	Caplet	833,182 L.L
N06AB10	ZELAX 20	G	Escitalopram (oxalate) - 20mg	20mg	Caplet	1,544,075 L.L
J01XX08	ZERSA	G	Linezolide - 600mg/300ml	600mg/300ml	Injectable solution	3,303,165 L.L
J01XX08	ZERSA	G	Linezolide - 100mg/5ml	100mg/5ml	Suspension	20,406,792 L.L
J01DD13	ZAKON	G	Cefpodoxime (proxetil) - 100mg/5ml	100mg/5ml	Powder for suspension	1,116,733 L.L
L01BC07	ZYDROME	G	Azacitidine - 100mg	100mg	Injectable lyophilised powder	10,967,854 L.L
N05AH03	ZOLAPINE	G	Olanzapine - 5mg	5mg	Tablet, orodispersible	1,186,165 L.L
N05AH03	ZYRWAN OD	G	Olanzapine - 5mg	5mg	Tablet, orodispersible	831,391 L.L
N05AH03	ZOLAPINE	G	Olanzapine - 10mg	10mg	Tablet, orodispersible	2,106,249 L.L
N05AH03	ZYRWAN OD	G	Olanzapine - 10mg	10mg	Tablet, orodispersible	2,564,819 L.L
A04AA01	ZONETRON ODT	G	Ondansetron - 8mg	8mg	Tablet, orodispersible	998,283 L.L
C08DB01	ZALDEM	G	Diltiazem HCl - 60mg	60mg	Tablet, scored	199,657 L.L